IFF RSI Chart
Last 7 days
2.8%
Last 30 days
3.8%
Last 90 days
3.4%
Trailing 12 Months
-10.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 12.2B | 11.9B | 11.6B | 11.5B |
2022 | 12.4B | 12.6B | 12.6B | 12.4B |
2021 | 6.2B | 8.1B | 9.9B | 11.7B |
2020 | 5.2B | 5.1B | 5.1B | 5.1B |
2019 | 4.3B | 4.7B | 5.1B | 5.1B |
2018 | 3.5B | 3.6B | 3.6B | 4.0B |
2017 | 3.2B | 3.2B | 3.3B | 3.4B |
2016 | 3.0B | 3.1B | 3.1B | 3.1B |
2015 | 3.1B | 3.1B | 3.1B | 3.0B |
2014 | 3.0B | 3.0B | 3.1B | 3.1B |
2013 | 2.8B | 2.9B | 2.9B | 3.0B |
2012 | 2.8B | 2.8B | 2.8B | 2.8B |
2011 | 2.7B | 2.7B | 2.8B | 2.8B |
2010 | 2.4B | 2.5B | 2.6B | 2.6B |
2009 | 0 | 2.4B | 2.3B | 2.3B |
2008 | 0 | 0 | 0 | 2.4B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | strzelecki angela | sold (taxes) | -29,502 | 83.34 | -354 | president, pharma solutions |
Apr 05, 2024 | johnson jennifer amy | acquired | - | - | 968 | evp, general counsel |
Apr 05, 2024 | johnson jennifer amy | sold (taxes) | -29,169 | 83.34 | -350 | evp, general counsel |
Apr 05, 2024 | herriott simon | acquired | - | - | 1,590 | pres. health & biosci. & scent |
Apr 05, 2024 | strzelecki angela | acquired | - | - | 1,140 | president, pharma solutions |
Apr 05, 2024 | herriott simon | sold (taxes) | -41,170 | 83.34 | -494 | pres. health & biosci. & scent |
Apr 01, 2024 | herriott simon | acquired | - | - | 1,489 | pres. health & biosci. & scent |
Apr 01, 2024 | herriott simon | sold (taxes) | -39,816 | 86.37 | -461 | pres. health & biosci. & scent |
Mar 01, 2024 | richter glenn r | sold (taxes) | -3,490 | 75.88 | -46.00 | cfo |
Mar 01, 2024 | johnson jennifer amy | acquired | - | - | 195 | evp, general counsel |
Which funds bought or sold IFF recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | Summit Trail Advisors, LLC | new | - | 203,362 | 203,362 | -% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -16.81 | -599,000 | 4,542,000 | 0.04% |
Apr 23, 2024 | Livforsakringsbolaget Skandia, Omsesidigt | unchanged | - | 1,579 | 29,670 | -% |
Apr 23, 2024 | FIFTH THIRD BANCORP | added | 1.38 | 83,226 | 1,169,030 | -% |
Apr 23, 2024 | NEW MEXICO EDUCATIONAL RETIREMENT BOARD | reduced | -3.01 | 32,000 | 1,107,000 | 0.04% |
Apr 23, 2024 | Principle Wealth Partners LLC | added | 100 | 427,929 | 808,650 | 0.03% |
Apr 23, 2024 | HALL LAURIE J TRUSTEE | reduced | -24.16 | -13,000 | 52,000 | 0.02% |
Apr 23, 2024 | Global Retirement Partners, LLC | unchanged | - | 2,664 | 35,514 | -% |
Apr 23, 2024 | Venturi Wealth Management, LLC | added | 108 | 12,145 | 22,186 | -% |
Apr 23, 2024 | Morton Brown Family Wealth, LLC | sold off | -100 | -16,194 | - | -% |
Unveiling International Flavors & Fragrances Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to International Flavors & Fragrances Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
APD | 52.2B | 12.4B | 22.34 | 4.2 | ||||
DOW | 40.2B | 44.6B | 60.93 | 0.9 | ||||
AVTR | 17.2B | 7.0B | 53.65 | 2.47 | ||||
CE | 16.9B | 10.9B | 8.64 | 1.55 | ||||
ALB | 13.5B | 9.6B | 8.6 | 1.41 | ||||
EMN | 11.3B | 9.2B | 12.65 | 1.23 | ||||
MID-CAP | ||||||||
CBT | 5.2B | 3.9B | 11.64 | 1.32 | ||||
BCPC | 4.5B | 922.4M | 41.81 | 4.92 | ||||
AVNT | 3.9B | 3.1B | 51.87 | 1.26 | ||||
ARCH | 2.9B | 3.1B | 6.33 | 0.93 | ||||
SMALL-CAP | ||||||||
CCF | 1.2B | 404.0M | 36.59 | 3 | ||||
ASIX | 711.3M | 1.5B | 13.02 | 0.46 | ||||
CMT | 173.7M | 357.7M | 8.55 | 0.49 | ||||
AREC | 105.7M | 16.7M | 9.54 | 6.31 | ||||
AMRS | 3.7M | - | -0.01 | 0.01 |
International Flavors & Fragrances Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -4.1% | 2,703 | 2,820 | 2,929 | 3,027 | 2,844 | 3,063 | 3,307 | 3,226 | 3,031 | 3,071 | 3,089 | 2,465 | 1,270 | 1,268 | 1,199 | 1,347 | 1,284 | 1,267 | 1,292 | 1,297 | 1,219 |
Gross Profit | -6.9% | 860 | 924 | 933 | 964 | 869 | 1,001 | 1,136 | 1,145 | 981 | 1,090 | 910 | 754 | 514 | 524 | 482 | 566 | 502 | 533 | 546 | 531 | 478 |
S&GA Expenses | 0% | 444 | 444 | 445 | 454 | 440 | 413 | 456 | 459 | 450 | 436 | 412 | 451 | 254 | 235 | 230 | 230 | 242 | 211 | 210 | 213 | 250 |
R&D Expenses | 0% | 157 | 157 | 161 | 161 | 143 | 145 | 158 | 157 | 166 | 156 | 164 | 143 | 101 | 89.00 | 81.00 | 86.00 | 86.00 | 85.00 | 85.00 | 91.00 | 83.00 |
EBITDA Margin | -159.4% | -0.09* | 0.15* | -0.04* | -0.03* | -0.01* | 0.00* | 0.18* | 0.18* | 0.15* | 0.15* | 0.14* | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -60.9% | 43.00 | 110 | 116 | 111 | 104 | 83.00 | 77.00 | 72.00 | 73.00 | 74.00 | 77.00 | 65.00 | 33.00 | 35.00 | 32.00 | 32.00 | 35.00 | 33.00 | 33.00 | 37.00 | 39.00 |
Income Taxes | -200.0% | -32.00 | 32.00 | 23.00 | 22.00 | 19.00 | 160 | 21.00 | 39.00 | 22.00 | 53.00 | 14.00 | -14.00 | 13.00 | 19.00 | 16.00 | 26.00 | 16.00 | 27.00 | 31.00 | 23.00 | 51.00 |
Earnings Before Taxes | -4576.3% | -2,641 | 59.00 | 50.00 | 14.00 | -5.00 | -2,035 | 130 | 285 | 114 | 250 | 44.00 | -54.00 | 79.00 | 105 | 104 | 153 | 96.00 | 157 | 169 | 135 | 66.00 |
EBT Margin | -2260.1% | -0.22* | 0.01* | -0.17* | -0.15* | -0.13* | -0.12* | 0.06* | 0.06* | 0.03* | 0.03* | 0.02* | - | - | - | - | - | - | - | - | - | - |
Net Income | -10524.0% | -2,606 | 25.00 | 27.00 | -9.00 | -18.00 | -2,197 | 107 | 244 | 99.00 | 194 | 28.00 | -42.00 | 71.00 | 85.00 | 87.00 | 124 | 88.00 | 127 | 136 | 109 | 16.00 |
Net Income Margin | -10480.1% | -0.22* | 0.00* | -0.19* | -0.17* | -0.15* | -0.14* | 0.05* | 0.05* | 0.02* | 0.03* | 0.02* | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 65.9% | 531 | 320 | 133 | -48.00 | 48.00 | 132 | -151 | -136 | 160 | 351 | 268 | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -7.2% | 30,978 | 33,395 | 34,459 | 34,965 | 35,470 | 35,522 | 34,537 | 39,304 | 39,747 | 39,658 | 40,252 | 40,864 | 40,817 | 13,555 | 13,085 | 12,989 | 12,689 | 13,287 | 12,985 | 13,348 | 13,211 |
Current Assets | -1.5% | 6,293 | 6,391 | 6,436 | - | 7,442 | 7,432 | 6,494 | 7,730 | 7,507 | 6,987 | 7,132 | 6,297 | 6,174 | 3,060 | 2,946 | 3,013 | 2,818 | 2,943 | 2,899 | 2,990 | 2,926 |
Cash Equivalents | 11.8% | 703 | 629 | 638 | 15.00 | 590 | 483 | 538 | 569 | 657 | 711 | 672 | 935 | 872 | 660 | 470 | 498 | 433 | 624 | 495 | 427 | 484 |
Inventory | -2.8% | 2,477 | 2,549 | 2,790 | 116 | 2,946 | 3,151 | 3,122 | 2,993 | 2,795 | 2,516 | 2,401 | 2,464 | 2,589 | 1,132 | 1,151 | 1,166 | 1,076 | 1,123 | 1,126 | 1,164 | 1,114 |
Net PPE | 2.8% | 4,240 | 4,126 | 4,218 | 77.00 | 4,224 | 4,203 | 4,055 | 4,177 | 4,295 | 4,368 | 4,295 | 4,566 | 4,587 | 1,458 | 1,380 | 1,356 | 1,339 | 1,387 | 1,314 | 1,316 | 1,294 |
Goodwill | -18.4% | 10,635 | 13,031 | 13,498 | 317 | 13,458 | 13,373 | 13,305 | 16,071 | 45.00 | 16,432 | 16,590 | 17,250 | 11,762 | 5,593 | 5,427 | 5,349 | 15.00 | 5,497 | 4,274 | 5,506 | 5,434 |
Current Liabilities | 2.0% | 3,758 | 3,683 | 3,932 | - | 4,874 | 3,728 | 3,626 | 4,720 | 4,032 | 3,633 | 3,579 | 3,227 | 3,261 | 1,904 | 1,616 | 1,344 | 1,427 | 1,552 | 1,412 | 1,150 | 1,144 |
Long Term Debt | 0.3% | 9,186 | 9,159 | 9,208 | - | 9,220 | 10,373 | 10,260 | 10,363 | 10,738 | 10,768 | 10,818 | 11,354 | 11,330 | 3,779 | 3,891 | 4,182 | 3,947 | 3,997 | 4,008 | 4,429 | 4,421 |
LT Debt, Non Current | 0.3% | 9,186 | 9,159 | 9,208 | - | 9,220 | 10,373 | 10,260 | 10,363 | 10,738 | 10,768 | 10,818 | 11,354 | 11,330 | 3,779 | 3,891 | 4,182 | 3,947 | 3,997 | 4,008 | 4,429 | 4,421 |
Shareholder's Equity | -13.9% | 14,611 | 16,978 | 17,655 | 41.00 | 17,761 | 17,655 | 16,921 | 20,293 | 20,965 | 21,117 | 21,473 | 21,800 | 21,681 | 6,322 | 6,090 | 6,001 | 5,841 | 6,229 | 6,067 | 6,210 | 6,154 |
Retained Earnings | -745.2% | -2,439 | 378 | 560 | - | 739 | 955 | 1,186 | 3,589 | 3,683 | 3,641 | 3,752 | 3,759 | 3,922 | 4,156 | 4,171 | 4,168 | 4,162 | 4,118 | 4,114 | 4,069 | 4,011 |
Additional Paid-In Capital | 0.0% | 19,874 | 19,865 | 19,851 | - | 19,844 | 19,841 | 19,832 | 19,826 | 19,823 | 19,826 | 19,817 | 19,800 | 19,796 | 3,853 | 3,848 | 3,838 | 3,835 | 3,823 | 3,816 | 3,806 | 3,803 |
Accumulated Depreciation | -100.0% | - | 2,242 | 2,186 | - | 2,085 | 1,977 | 1,978 | 1,961 | 1,889 | 1,793 | 1,608 | 1,582 | 1,501 | 1,470 | 1,409 | 1,342 | 1,293 | 1,304 | 1,303 | 1,315 | 1,287 |
Shares Outstanding | 0.0% | 255 | 255 | 255 | - | 255 | 255 | 255 | 255 | 255 | 243 | 254 | 230 | 206 | - | - | - | - | - | - | - | - |
Minority Interest | 0% | 31.00 | 31.00 | 32.00 | - | 32.00 | 30.00 | 68.00 | 86.00 | 101 | 105 | 105 | 100 | 102 | 98.00 | 100 | 98.00 | 103 | 99.00 | 115 | 116 | 115 |
Float | - | - | - | 20,313 | - | - | - | - | 30,369 | - | - | - | 37,208 | - | - | - | 13,568 | - | - | - | 15,492 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 53.3% | 644 | 420 | 248 | 127 | 208 | 240 | -47.00 | -4.00 | 311 | 428 | 340 | 358 | 299 | 207 | 191 | 17.00 | 316 | 198 | 138 | 47.00 | 236 |
Share Based Compensation | -16.7% | 15.00 | 18.00 | 20.00 | 12.00 | 12.00 | 12.00 | 16.00 | 9.00 | 10.00 | 17.00 | 16.00 | 11.00 | 9.00 | 8.00 | 10.00 | 9.00 | 8.00 | 8.00 | 11.00 | 8.00 | 7.00 |
Cashflow From Investing | -174.4% | -64.00 | 86.00 | 719 | -167 | -142 | 1,233 | -225 | -121 | -93.00 | 45.00 | -85.00 | 115 | -68.00 | -42.00 | -34.00 | -43.00 | -68.16 | -11.60 | -55.94 | -90.30 | -4,910 |
Cashflow From Financing | -30.7% | -558 | -427 | -944 | 78.00 | -142 | -1,464 | 282 | 95.00 | -282 | -595 | -212 | -215 | -94.00 | -203 | -108 | -107 | -139 | -131 | -122 | -112 | 50.00 |
Dividend Payments | 0.5% | 207 | 206 | 207 | 206 | 206 | 202 | 201 | 201 | 201 | 192 | 192 | 82.00 | 83.00 | 80.00 | 80.00 | 80.00 | 81.00 | 78.00 | 78.00 | 78.00 | 67.00 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 |
CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net sales | $ 11,479 | $ 12,440 | $ 11,656 |
Cost of goods sold | 7,798 | 8,289 | 7,921 |
Gross profit | 3,681 | 4,151 | 3,735 |
Research and development expenses | 636 | 603 | 629 |
Selling and administrative expenses | 1,787 | 1,768 | 1,749 |
Restructuring and other charges | 68 | 12 | 41 |
Amortization of acquisition-related intangibles | 680 | 727 | 732 |
Impairment of goodwill | 2,623 | 2,250 | 0 |
Impairment of long-lived assets | 0 | 120 | 0 |
Gains on sale of assets | (3) | (3) | (1) |
Operating (loss) profit | (2,110) | (1,326) | 585 |
Interest expense | 380 | 336 | 289 |
Other expense (income), net | 28 | (37) | (58) |
(Loss) income before taxes | (2,518) | (1,625) | 354 |
Provision for income taxes | 45 | 239 | 75 |
Net (loss) income | (2,563) | (1,864) | 279 |
Net income attributable to non-controlling interest | 4 | 7 | 9 |
Net income available to IFF common shareholders | (2,567) | (1,871) | 270 |
Other comprehensive income (loss), after tax: | |||
Foreign currency translation adjustments | 414 | (933) | (848) |
Gains on derivatives qualifying as hedges | 0 | 0 | 8 |
Pension and postretirement liability adjustment | (112) | 158 | 115 |
Other comprehensive income (loss) | 302 | (775) | (725) |
Comprehensive loss | (2,261) | (2,639) | (446) |
Comprehensive loss attributable to IFF shareholders | $ (2,265) | $ (2,646) | $ (455) |
Net income per share - basic (in dollars per share) | $ (10.05) | $ (7.32) | $ 1.11 |
Net income per share - diluted (in dollars per share) | $ (10.05) | $ (7.32) | $ 1.10 |
Average number of shares outstanding - basic (in shares) | 255 | 255 | 243 |
Average number of shares outstanding - diluted (in shares) | 255 | 255 | 243 |
CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 703 | $ 483 |
Restricted cash | 6 | 10 |
Receivables, net, current | 1,726 | 1,818 |
Inventories | 2,477 | 3,151 |
Assets held for sale | 506 | 1,200 |
Prepaid expenses and other current assets | 875 | 770 |
Total Current Assets | 6,293 | 7,432 |
Property, plant and equipment, net | 4,240 | 4,203 |
Goodwill | 10,635 | 13,373 |
Other intangible assets, net | 8,357 | 9,082 |
Operating lease right-of-use assets | 689 | 743 |
Other assets | 764 | 689 |
Total Assets | 30,978 | 35,522 |
Current Liabilities: | ||
Bank borrowings, overdrafts and current portion of long-term debt | 885 | 410 |
Commercial paper | 0 | 187 |
Accounts payable | 1,378 | 1,418 |
Accrued payroll and bonus | 265 | 267 |
Dividends payable | 207 | 206 |
Liabilities held for sale | 46 | 212 |
Other current liabilities | 977 | 1,028 |
Total Current Liabilities | 3,758 | 3,728 |
Other Liabilities: | ||
Long-term debt | 9,186 | 10,373 |
Retirement liabilities | 253 | 231 |
Deferred income taxes | 1,937 | 2,283 |
Operating lease liabilities | 642 | 672 |
Other liabilities | 560 | 491 |
Total Other Liabilities | 12,578 | 14,050 |
Commitments and Contingencies (Note 19) | ||
Redeemable non-controlling interests | 0 | 59 |
Shareholders’ Equity: | ||
Common stock, value, issued | 35 | 35 |
Capital in excess of par value | 19,874 | 19,841 |
(Accumulated deficit) retained earnings | (2,439) | 955 |
Accumulated other comprehensive loss | (1,896) | (2,198) |
Treasury stock, value | (963) | (978) |
Total Shareholders’ Equity | 14,611 | 17,655 |
Non-controlling interest | 31 | 30 |
Total Shareholders’ Equity including non-controlling interest | 14,642 | 17,685 |
Total Liabilities and Shareholders’ Equity | $ 30,978 | $ 35,522 |
 | Mr. Franklin K. Clyburn Jr. |
---|---|
 | iff.com |
 | Chemicals |
 | 24600 |